SEC Clinical Research — Dothan, Alabama

SEC Clinical Research is a clinical research site located in Dothan, Alabama, United States 36305.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

SEC Clinical Research has participated in 12 clinical trials with 7 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Heart Failure.

Sponsors: Eli Lilly and Company, Novartis Pharmaceuticals, Mylan Pharmaceuticals Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SEC Clinical Research?

SEC Clinical Research has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SEC Clinical Research conducted?

SEC Clinical Research has 12 clinical trials on record, with 7 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Heart Failure.

Is SEC Clinical Research accredited by Crixeo Health?

Yes — SEC Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about SEC Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.